COVID-19 Research
For researchers
- Funding opportunities
- Resources
- News
- FAQs
COVID-19 Research
As the federal funding agency responsible for investing in health research, CIHR has been central to Canada’s response to COVID-19.
Since March 2020, CIHR has invested approximately $250 million in more than 400 COVID-19 research projects. These projects span everything from diagnostics and potential treatments to public health responses and communication strategies.
CIHR has also worked with partners to invest in Canadian COVID-19 research with dedicated funding for specific topics such as:
- Indigenous communities’ experiences with COVID-19;
- addressing the mental health and substance use challenges facing Canadians during the pandemic;
- how to keep residents and staff of long-term care homes safe from COVID-19; and
- developing guidelines related to prescribing and dispending opioids during the pandemic.
CIHR also has engaged with our international partners to ensure the alignment and coordination of Canada’s research with the international response.
CIHR COVID-19 Investments: By the Numbers
CIHR and its partners have jointly invested more than $250 million in COVID-19 research since the start of the pandemic.
Canadian impacts: Research to address COVID-19
These stories highlight the various ways in which health research is contributing to Canada's response to the COVID-19 pandemic.
COVID-19 and Mental Health
Initiative supporting the mental health of Canadians in the COVID-19 context.
COVID-19 and Indigenous Health
Funding opportunities, featured research, and culturally safe resources
- Date modified: